Pursuant to Regulation 30 of SEBI Listing Regulations, Sai Life Sciences has informed that it enclosed the ‘Press Release on Un-audited Standalone and Consolidated Financial Results for the second quarter and half year ended 30th September 2026’ being issued by the Company. Further, the above-mentioned press release is also available on the Website of the Company.
The above information is a part of company’s filings submitted to BSE.